INSIGHTS ON PHARMACEUTICAL PACKAGING

• Determining The Limit Of Detection In CCIT

  Accurately determining the smallest detectable defect in pharmaceutical packaging is essential for sterility. Learn how test sensitivity, positive controls, and regulatory standards shape CCI strategies.

• FAQs On The Revised EU GMP Annex 1: Volume 2

  Review the implementation of a holistic Contamination Control Strategy (CCS). Discover four key considerations for assessing component readiness: product, process, protection, and proof.

• Overcome Common Pre-Filled Syringe Challenges Through Partnership

  The pre-filled syringe space is one of the fastest growing pharma sectors, offering greater patient safety and lower manufacturing costs. But pre-filled doesn’t translate to easily filled; there are particular obstacles to overcome.

• Find Flexibility And Scalability With Modular Assembly Equipment

  Find tailor-made solutions designed to deliver high-quality standards even when scaling up. Modularity enhances production efficiency, saves costs, and shortens time to market.

• Nebulizers: Package Integrity Testing Challenges And Solutions

  1/5/2026

  Maintaining sterile packaging for nebulizer drugs is vital to prevent contamination. Learn how regulatory standards and advanced leak detection methods address integrity challenges in high-risk formats.

• Low Temperature Storage Containment For Vial And Syringe Systems

  6/20/2025

  With the growth of advanced therapy medicinal products, there is an increased need for specialized low-temperature packaging solutions, particularly for vials and syringe systems at -50°C to ≤ -130°C.

• PCI Pharma Services Capabilities Update January 2026: Fill/Finish

  2/4/2026

  Patricia highlights PCI’s global sterile fill‑finish and lyophilization strengths, showcasing investments that expand capacity, technologies, and integrated solutions for complex biologics, formulations, and lyophilized products.

• A Practical Packaging Components Checklist For Emerging Biotechs

  6/20/2024

  A proactive approach to packaging development can ultimately ensure a smoother launch. Explore five key considerations when selecting components for your injectable drug product.

• New Standards For Elastomeric Components In Sterile Packaging

  1/20/2026

  USP’s new elastomeric packaging standards shift testing to full system‑level evaluation, strengthen integrity and usability expectations, and place compliance responsibility on drug developers.